Investors
A proven track record of value creation
Our robust business model provides significant opportunities to drive growth and deliver value for investors.
Together we’re building a leading global pharmaceutical business
By putting better health within reach of patients every day through investment, innovation and diversification, we’re enhancing our portfolio responsibly and creating strong shareholder returns.
H1 2025 Interim Results
Watch Riad Mishlawi, CEO
Latest stories
Featured
Hikma delivers a solid H1 performance and re-affirms expectations for strong growth in the second half
Press Release, Financial Results
07 August 2025
- Hikma R&D Formulation Development Innovation. Meet Timothy Owen Story, Life at Hikma 15 September 2025 Hikma R&D Formulation Development Innovation. Meet Timothy Owen
- Hikma R&D Analytical Research Innovation. Meet Seham Samawi Story, Life at Hikma 03 September 2025 Hikma R&D Analytical Research Innovation. Meet Seham Samawi
- Hikma R&D Formulation Development Innovation. Meet Mihir Modh Story, Life at Hikma 26 August 2025 Hikma R&D Formulation Development Innovation. Meet Mihir Modh
- Acting responsibly for purpose-driven impact: How Hikma champions inclusive education Insight, Responsibility 25 August 2025 Acting responsibly for purpose-driven impact: How Hikma champions inclusive education
